Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FQAJT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,728
Award facts
- Contract value 100% obligated
- $3,727.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,727.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure comprehensive pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for an extensive portfolio of medical products ranging from prescription medications to biologics and medical consumables. The company's federal procurement track record demonstrates its capability to deliver specialized pharmaceutical items, including oncology treatments, vaccines, and other medical products directly to Department of Defense healthcare sites across the nation. This particular delivery order for Photrexa Cross-Linking Kit represents one of numerous firm fixed-price orders the company fulfills under its master contract with the DLA.
Quick answers
Who was awarded contract SPE2DB25FQAJT?
SPE2DB25FQAJT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQAJT worth?
The government has obligated $3,728 on SPE2DB25FQAJT.
Is contract SPE2DB25FQAJT an order under another contract?
Yes. SPE2DB25FQAJT is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJT competed?
The extent of competition for SPE2DB25FQAJT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award